Catalyst Wire Dossier Catalyst Wire Dossier

gelrinC

· Regentis Biomaterials
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for gelrinC, covering 2017-10-09 to 2017-10-09. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Performance of Treatment of Articular Cartilage Lesions Located on the Femoral Condyle With gelrinC [Phase 1, Phase 2]

See pricing